People have been celebrating the summer solstice with elaborate rituals since prehistoric times. But humans aren't the only ...

People have been celebrating the summer solstice with elaborate rituals since prehistoric times. But humans aren’t the only ...

Nicole Verdun, director of the office that reviews cell and gene therapies at the Food and Drug Administration, and her ...

Zhejiang Jingke Pharmaceuticals Co. Ltd. has identified mast/stem cell growth factor receptor kit (KIT; c-Kit; CD117) inhibitors reported to be useful for the treatment of cancer, neurodegeneration, ...

Sanofi acquires Blueprint Medicines Corporation for $9.1bn, gaining revenue-driving Aykavit and pipeline drug BLU-808 ...

Calviri, Inc, a company focused on ending cancer in dogs and people, announces the publication of High-sensitivity multicancer detection of stage 1 cancer in dogs in the American Journal of Veterinary ...

Shares of Jasper Therapeutics rose after the company disclosed what it called positive data from a recent trial of its treatment for chronic mast cell diseases. The stock climbed 13%, to $6.32, in ...

The therapy targets mast cells by inhibiting receptor tyrosine kinase KIT, crucial for mast cell function and survival. Significant improvements in UAS7 and quality of life were observed.

Celldex (NASDAQ:CLDX) announced today new data demonstrating profound, sustained complete response and improved quality of life at 76 weeks, 7 months after the completion of dosing with barzolvolimab ...

Mast cell tumors (MCT) are the most common type of skin tumor in dogs. These cancerous tumors consist of the mast cells that give them their name. About 20 percent of skin tumors in our canine ...